MetaCap

Azenta (AZTA) vs Embecta (EMBC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Azenta (AZTA) has outperformed Embecta (EMBC) over the past year, gaining 16.8% versus a loss of 57.1%. Azenta is the larger company by market cap ($1.55 billion vs $329.5 million), about 4.7 times the size. On valuation, Embecta trades at a lower forward P/E (3.3x vs 63.9x for Azenta).

Embecta pays a dividend yielding 7.91%, while Azenta does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AZTA+16.79%EMBC-57.11%
+45%-20%-85%
Oct 7, 20251 yearOct 7, 2026
AZTA-57.92%EMBC-86.26%
+5%-46%-97%
Mar 21, 20225 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AZTA versus EMBC key metrics
MetricAZTAEMBC
Share price$35.32$5.82
Market cap$1.55B$329.48M
1-day change-1.59%-1.61%
YTD return+7.91%-50.25%
1-year return+16.79%-57.11%
5-year return-65.31%—
P/E ratio (TTM)—3.96
Forward P/E63.933.30
EPS (TTM)$-2.47$1.47
Dividend yield0.00%7.91%
Annual dividend$0.00$0.46
52-week high$46.41$14.91
52-week low$15.93$2.77
Distance from 52-week high-23.90%-61.00%
Analyst consensusbuynone
Avg. price target upside+4.76%-31.21%
Average volume865.89K1.37M
Shares outstanding43.81M56.66M
Employees2,9001,850
SectorTechnologyHealth Care
IndustryIndustrial Machinery/ComponentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Azenta is about 4.7 times larger than Embecta by market value ($1.55B vs $329.48M).
  • AZTA has outperformed EMBC by 73.9 percentage points over the past year.
  • Embecta offers a meaningfully higher dividend yield (7.91% vs 0.00%).
  • The two companies sit in different sectors: Azenta in Technology and Embecta in Health Care.

About Azenta

AZTA stock →

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Technology · Industrial Machinery/Components · 2,900 employees

About Embecta

EMBC stock →

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.

Health Care · Medical/Dental Instruments · 1,850 employees

AZTA vs EMBC FAQ

Which is bigger, Azenta or Embecta?

Azenta (AZTA) is larger, with a market capitalization of $1.55B compared with $329.48M for Embecta (EMBC).

Which stock has performed better over the past year, AZTA or EMBC?

AZTA returned +16.79% over the past 12 months, compared with -57.11% for EMBC (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Azenta or Embecta?

Embecta pays a dividend yielding 7.91%, while Azenta does not currently pay a regular dividend.

Are Azenta and Embecta in the same industry?

No. Azenta is in the Technology sector, while Embecta is in Health Care.

More comparisons